Also known as: Solar Daze F2

Solar Daze

A modern hybrid associated with Ethos Genetics, marketed as a calm, daytime-leaning cross with limited independent verification.

Sourced and fact-checked
8 cited sources
Published 6 days ago
How this page was made
↯ The honest take

Solar Daze is a relatively recent Ethos Genetics release with a small public footprint. Most of what you'll read about its effects, terpene profile, and yield comes from the breeder's own marketing copy and a handful of grower forum posts — there is no independent lab data set, no peer-reviewed work, and no clinical research on this specific cultivar. Treat the published THC ranges and effect descriptions as ballpark estimates from interested parties, not measured facts. The genetics story is plausible but not independently verified.

Overview

Solar Daze is a hybrid cannabis cultivar associated with Ethos Genetics, a Colorado-based breeder known for chem- and cookie-family hybrids [1]. It circulates primarily as seed stock rather than as a widely stocked dispensary flower, which means most consumer-facing information about it comes from breeder descriptions and grower communities rather than retail lab panels.

Unlike legacy strains such as Northern Lights or Haze, Solar Daze has no decades-long paper trail. It should be understood as a modern, niche hybrid whose reputation is still being built. No data

Chemistry: cannabinoids and terpenes

Cannabinoids. Breeder copy and scattered grower reports place Solar Daze's THC in the rough 20-26% range, with negligible CBD Weak / limited. No independent aggregated dataset (e.g. from a state testing program or peer-reviewed chemotype survey) has been published for this cultivar specifically.

Terpenes. Public sources describe a sweet, slightly gassy profile and suggest myrcene and limonene dominance, sometimes with caryophyllene Anecdote. These descriptions are sensory, not chromatographic. Cannabis terpene expression is also strongly influenced by phenotype selection, cure, and environment, so even if one grower's Solar Daze tests myrcene-dominant, another's may not [2][3].

A broader caution: the popular framing that a single terpene above some threshold (the often-repeated "myrcene >0.5% = couch-lock" claim) predicts effects is folklore. It is not supported by controlled human research Disputed[4].

Reported effects

Users and the breeder describe Solar Daze as relaxing, mood-lifting, and mildly sedating — a "daze" rather than a knockout Anecdote. Some reviewers position it as a late-afternoon or evening smoke.

Important caveats:

If you see a dispensary budtender confidently describe Solar Daze's effects in clinical terms ("treats anxiety," "helps insomnia"), that is marketing, not medicine.

Lineage

Ethos has publicly described Solar Daze as part of its hybrid lineup developed from in-house breeding stock, with reported parentage involving Ethos cookie/cake-family lines [1] Weak / limited. Exact pollen-donor and mother selections vary by release batch (F1, F2, etc.), and the breeder has reformulated several lines over time.

Because cannabis seed lines are rarely subjected to independent genetic verification, all strain lineages — Solar Daze included — should be treated as breeder-reported rather than confirmed. Genotyping studies have repeatedly shown that strain names are an unreliable guide to actual genetic relationships Strong evidence[8].

Cultivation basics

Public grow notes (forum posts, seed-bank descriptions) suggest:

Phenotype variation matters: if you pop a pack of seeds, expect a range of expressions in vigor, terpene profile, and finish time. Selecting a keeper requires running multiple plants.

Marketing vs. reality

What's reasonable to say about Solar Daze:

What is not supported:

If you want to know what's actually in the Solar Daze you're buying, read the Certificate of Analysis for that batch. That single document is worth more than every strain review on the internet combined.

Sources

  1. Practitioner Ethos Genetics. Official strain catalog and breeder descriptions. Ethos Genetics, Denver, CO.
  2. Peer-reviewed Booth, J.K., & Bohlmann, J. (2019). Terpenes in Cannabis sativa – From plant genome to humans. Plant Science, 284, 67-72.
  3. Peer-reviewed Aizpurua-Olaizola, O. et al. (2016). Evolution of the cannabinoid and terpene content during the growth of Cannabis sativa plants from different chemotypes. Journal of Natural Products, 79(2), 324-331.
  4. Peer-reviewed Piomelli, D., & Russo, E.B. (2016). The Cannabis sativa versus Cannabis indica debate: An interview with Ethan Russo, MD. Cannabis and Cannabinoid Research, 1(1), 44-46.
  5. Peer-reviewed Gukasyan, N., & Strain, E.C. (2020). Relationship between cannabis use frequency and major depressive disorder in adolescents: Findings from the National Survey on Drug Use and Health 2012-2017. Drug and Alcohol Dependence, 208, 107867. (Cited for general note on expectancy and self-report limitations in cannabis research.)
  6. Peer-reviewed Smith, C.J., Vergara, D., Keegan, B., & Jikomes, N. (2022). The phytochemical diversity of commercial Cannabis in the United States. PLOS ONE, 17(5), e0267498.
  7. Peer-reviewed Sharpe, L., Sinclair, J., Kramer, A., de Manincor, M., & Sarris, J. (2020). Cannabis, a cause for anxiety? A critical appraisal of the anxiogenic and anxiolytic properties. Journal of Translational Medicine, 18, 374.
  8. Peer-reviewed Sawler, J. et al. (2015). The genetic structure of marijuana and hemp. PLOS ONE, 10(8), e0133292.

How this page was made

Generation history

May 5, 2026
Fact-check pass — raised 2 flags
May 4, 2026
Initial draft

Drafting assistance and fact-check automation are used, with a human operator spot-checking on a weekly basis. See how articles are made.